An open-label pilot study of the combination therapy of metformin and fluoxetine for weight reduction
β Scribed by Siavash Dastjerdi, M; Kazemi, F; Najafian, A; Mohammady, M; Aminorroaya, A; Amini, M
- Book ID
- 110046032
- Publisher
- Nature Publishing Group
- Year
- 2006
- Tongue
- English
- Weight
- 95 KB
- Volume
- 31
- Category
- Article
- ISSN
- 1476-5497
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective To assess the efficacy of duloxetine for irritable bowel syndrome (IBS). ## Methods We conducted an openβlabel 12βweek trial of duloxetine 60βmg daily in 15 patients with IBS without concurrent major depressive disorder. The primary outcome measure was average abdominal
## Background: Extracorporeal photopheresis (ecp) is effective in immune-mediated disorders. a prospective, uncontrolled pilot study was conducted to evaluate the safety and efficacy of ecp in patients with active crohn's disease (cd) who were refractory to or intolerant of immunosuppressants and/o
## Abstract ## Objectives The atypical antipsychotics are being increasingly used to control acute manic episodes, and data are emerging to support their moodβstabilizing and antidepressant properties. This study investigated the shortβterm efficacy of quetiapine as an addβon therapy in the treatm